Advancing data surround retatrutide, a dual stimulant for GLP-1R and GIPR, reveal encouraging potential in managing excess body fat and associated metabolic conditions. Preliminary testing indicate notable weight loss https://retatrutideresearchlab.co.uk/product-category/pharmaceutical-research-reference/